STEPHANIE PASLEY: Open Payments
NPI 1881149219 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 35 payments from 14 companies in 2025. Trend: 2023 $872 · 2024 $583 · 2025 $781
Food & beverage: $700Education: $81
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $155 |
| GENZYME CORPORATION | 3 | $84 |
| Regeneron Healthcare Solutions, Inc. | 1 | $81 |
| UCB, Inc. | 3 | $78 |
| Galderma Laboratories, L.P. | 2 | $62 |
| Biofrontera Inc. | 3 | $54 |
| Amgen Inc. | 1 | $45 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $43 |
| Organon LLC | 4 | $42 |
| ABBVIE INC. | 2 | $35 |
Products named: DUPIXENT, COSENTYX, Bimzelx, NEMLUVIO, XOLAIR, OTEZLA, VTAMA, AMELUZ.
Industry payments across AZ — which companies pay providers there.
